Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

about

Triazole Resistance in Aspergillus Species: An Emerging Problem.Correction: Stewart, E.R.; Thompson, G.R. Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence. J. Fungi 2016, 2, 25.

P2860

Q30235566-8453F58A-5E31-4DCC-906E-9F8B85B33E86 Q48509887-190194B3-D3DE-4ABD-B042-6CBED141DD9B

P2860

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

Item

http://www.wikidata.org/entity/Q47697132

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

@en

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

@nl

type

Item

label

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

@en

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

@nl

prefLabel

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

@en

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

@nl

P1476

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

@en

P2093

Ethan R Stewart

http://www.w3.org/2001/XMLSchema#string

George R Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.

Aspergillus valve endocarditis in patients without prior cardiac surgery.

AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

P31

scholarly article

P356

10.3390/JOF2030025

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29376942

http://www.w3.org/2001/XMLSchema#string

P932

5753138

http://www.w3.org/2001/XMLSchema#string

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

about

P2860

P2860

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P932